{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:26:49Z","timestamp":1794360409491,"version":"4.9.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/03007995.2025.2571036","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T07:49:16Z","timestamp":1759909756000},"page":"1641-1653","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["The cost of migraine to the NHS in England: a retrospective cohort study using electronic health record data from Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)"],"prefix":"10.1080","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-4020","authenticated-orcid":false,"given":"S.","family":"Collings","sequence":"first","affiliation":[{"name":"Pfizer Ltd","place":["Tadworth, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1545-7946","authenticated-orcid":false,"given":"Amisha","family":"Patel","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0347-4670","authenticated-orcid":false,"given":"Hannah","family":"Gowman","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Law","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8912-6237","authenticated-orcid":false,"given":"Aideen","family":"Ahern","sequence":"additional","affiliation":[{"name":"Pfizer Healthcare Ireland","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0769-6219","authenticated-orcid":false,"given":"Robert","family":"Pawinski","sequence":"additional","affiliation":[{"name":"Pfizer Ltd","place":["Tadworth, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6977-435X","authenticated-orcid":false,"given":"Robert","family":"Wood","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8487-5677","authenticated-orcid":false,"given":"Shazia K.","family":"Afridi","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Trust Foundation","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"National Institute for Health and Care Excellence (NICE). Migraine: what is it?. 2024. https:\/\/cks.nice.org.uk\/topics\/migraine\/background-information\/definition\/"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00568.x"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21244-8"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3"},{"key":"e_1_3_5_8_1","unstructured":"NHS England. Improved NHS migraine care to save thousands of hospital stays. 2020. https:\/\/www.england.nhs.uk\/2020\/01\/improved-nhs-migraine-care\/"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.36469\/jheor.2023.87790"},{"key":"e_1_3_5_10_1","unstructured":"National Institute of Health and Care Excellence (NICE). Rimegepant for treating migraine. Technology appraisal guidance [TA919]. Accessed Technology appraisal guidance [TA919]. 2023. https:\/\/www.nice.org.uk\/guidance\/ta919"},{"key":"e_1_3_5_11_1","unstructured":"National Institute for Health and Care Excellence (NICE). Eptinezumab for preventing migraine. Technology appraisal guidance [TA871]. https:\/\/www.nice.org.uk\/guidance\/ta871]. 2023."},{"key":"e_1_3_5_12_1","unstructured":"National Institute for Health and Care Excellence (NICE). Fremanezumab for preventing migraine. Technology appraisal guidance [TA764]. 2022. https:\/\/www.nice.org.uk\/guidance\/ta764"},{"key":"e_1_3_5_13_1","unstructured":"National Institute for Health and Care Excellence (NICE). Erenumab for preventing migraine. Technology appraisal guidance [TA682]. 2021. https:\/\/www.nice.org.uk\/guidance\/ta682"},{"key":"e_1_3_5_14_1","unstructured":"National Institute for Health and Care Excellence (NICE). Galcanezumab for preventing migraine. Technology appraisal guidance [TA659]. https:\/\/www.nice.org.uk\/guidance\/ta659]. 2020."},{"key":"e_1_3_5_15_1","unstructured":"British Association for the Study of Headache (BASH). National headache management system for adults. 2019. https:\/\/bash.org.uk\/wp-content\/uploads\/2023\/02\/01_BASHNationalHeadache_Management_SystemforAdults_2019_guideline_versi.pdf"},{"key":"e_1_3_5_16_1","unstructured":"National Institute for Health and Care Excellence (NICE). Headaches in over 12s: diagnosis and management. Clinical guideline [CG150]. Published 19 September 2012. 2021. https:\/\/www.nice.org.uk\/guidance\/cg150"},{"key":"e_1_3_5_17_1","unstructured":"National Institute of Health and Care Excellence (NICE). Atogepant for preventing migraine. Technology appraisal guidance [TA973]. 2024. https:\/\/www.nice.org.uk\/guidance\/ta973"},{"key":"e_1_3_5_18_1","unstructured":"National Institute for Health and Care Excellence (NICE). Rimegepant for preventing migraine. Technology appraisal guidance [TA906]. 2023. https:\/\/www.nice.org.uk\/guidance\/ta906"},{"key":"e_1_3_5_19_1","unstructured":"National Institute for Health and Care Excellence (NICE). Scenario: migraine in adults. 2024. https:\/\/cks.nice.org.uk\/topics\/migraine\/management\/adults\/."},{"key":"e_1_3_5_20_1","unstructured":"University Hospitals Birmingham. Migraine referral pathway. 2024. https:\/\/www.uhb.nhs.uk\/gps\/referrals\/referrals-by-specialty\/neurology\/migraine-referral-pathway\/."},{"key":"e_1_3_5_21_1","unstructured":"Referral SWDFa. Adult migraine with and without aura referral guidelines for GPs. 2025. https:\/\/southwest.devonformularyguidance.nhs.uk\/referral-guidance\/south-devon-torbay\/neurology\/adult-migraine-with-or-without-aura-referral-guidelines-for-gps."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.073221"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp08X264072"},{"key":"e_1_3_5_24_1","unstructured":"The Migraine Trust. What is the impact of migraine in the UK?. 2020. https:\/\/migrainetrust.org\/wp-content\/uploads\/2021\/08\/State-of-the-Migraine-Nation-impact-rapid-review.pdf."},{"key":"e_1_3_5_25_1","unstructured":"NHS Digital. Hospital admitted patient care activity. national statistics accredited official statistics. 2024. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/hospital-admitted-patient-care-activity"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0442-4"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.48329\/t89s-kf12"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.48329\/q34f-f505"},{"key":"e_1_3_5_29_1","unstructured":"Clinical Practice Research Datalink (CPRD). Small area level data based on practice postcode - Documentation and Data Dictionary. 2022. https:\/\/cprd.com\/sites\/default\/files\/2022-05\/Documentation_SmallAreaData_Practice_set22_v3.4_1.pdf"},{"key":"e_1_3_5_30_1","unstructured":"NHS England. Past national tariffs: documents and policies. Published 11 February 2021. 2023. https:\/\/www.england.nhs.uk\/publication\/past-national-tariffs-documents-and-policies\/"},{"key":"e_1_3_5_31_1","unstructured":"Payment - HRG4\u2009+\u20092017\/18 local payment grouper. NHS Digital: NHS; 2018."},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06178-6"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04643-8"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01798-z"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20100"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418767999"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59700"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1034-8"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2340932"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14247"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-1084-y"},{"key":"e_1_3_5_42_1","unstructured":"The Migraine Trust. Migraine preventive treatments: CGRP monoclonal antibodies and Botox. 2023. https:\/\/migrainetrust.org\/news\/migraine-preventive-treatments-cgrp-monoclonal-antibodies-and-botox\/"},{"issue":"2","key":"e_1_3_5_43_1","first-page":"A53","article-title":"Practice variation in UK neurology management of episodic migraine (EM)","volume":"95","author":"Rafi K","year":"2024","unstructured":"Rafi K, Jennifer B, Shaan T, et al. Practice variation in UK neurology management of episodic migraine (EM). J Neurol Neurosurg Psychiatry. 2024;95(Suppl 2):A53\u2013A53.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_5_44_1","unstructured":"Getting It Right First (GIRFT). Neurology. GIRFT programme national speciality report. 2021. https:\/\/www.gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2022\/06\/Neurology-Sept21g.pdf"},{"key":"e_1_3_5_45_1","unstructured":"The Migraine Trust. Heading in the wrong direction: Challenges in migraine care and why people with migraine deserve better. 2023. https:\/\/migrainetrust.org\/wp-content\/uploads\/2023\/09\/TMT-Heading-In-The-Wrong-Direction-2023-FINAL.pdf"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14106"},{"key":"e_1_3_5_47_1","unstructured":"National Institute for Heath and Care Excellence. Migraine: how common is it?. 2022. https:\/\/cks.nice.org.uk\/topics\/migraine\/background-information\/prevalence\/#:\u223c:text=Migraine%20can%20occur%20at%20any in%20primary%20and%20secondary%20care"},{"key":"e_1_3_5_48_1","unstructured":"NHS Digital. Advice and guidance overview for the NHS e-Referral Service (e-RS). 2024. https:\/\/digital.nhs.uk\/services\/e-referral-service\/document-library\/advice-and-guidance-overview"},{"key":"e_1_3_5_49_1","unstructured":"NHS England. Clinically-led Neurology Outpatient Guidance. 2023. https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2023\/07\/ClinicallyledNeurologyOutpatientGuideJuly23FINAL-V1.pdf"},{"key":"e_1_3_5_50_1","unstructured":"NHS England. Further faster programme. 2023. https:\/\/gettingitrightfirsttime.co.uk\/cross_cutting_theme\/further-faster-programme\/"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241276415"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-00221-w"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2025.2571036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:03:10Z","timestamp":1763564590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2025.2571036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/03007995.2025.2571036"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2025.2571036","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}